Vitamin-C verdict may spell trouble ahead for multinational Chinese companies
On 14 March, a federal jury in New York found Chinese vitamin-C manufacturer Hebei Welcome Pharmaceutical Co and its parent, North China Pharmaceutical Group Corp, liable for agreeing with other Chinese manufacturers to fix prices in the vitamin-C market.
The jury awarded $54.1m (£35m) in damages to the plaintiffs — purchasers including US food and drink companies, packagers, wholesalers and distributors — an amount that was then trebled by the presiding judge to an award of $162.3m in accordance with federal antitrust laws. Three other Chinese manufacturers involved in the conspiracy reached settlements with the plaintiffs prior to the announcement of the verdict…
If you are registered and logged in to the site, click on the link below to read the rest of the Allen & Overy briefing. If not, please register or sign in with your details below.
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
Federal regulators have voted to approve the ‘Volcker Rule’, more than two years after the rule’s proposal in 2011.
In March 2013 the European Commission consulted on proposals to simplify procedures under the EU merger regulation.
Analysis from The Lawyer
Advisers get stuck into the disentangling task, to unhitch troubled bank from group
Shell legal director Peter Rees is switching litigation control away from external counsel to a unified global team of in-housers